Showing 1,461 - 1,480 results of 2,274 for search '"type 2 diabetes"', query time: 0.14s Refine Results
  1. 1461

    Sick Day Management for Adults with Diabetes Who Take Insulin by Nancy Gal, Linda B. Bobroff

    Published 2017-08-01
    “… When people have type 1 or type 2 diabetes and take multiple daily insulin injections, their blood glucose levels can rise drastically due to a cold or another minor illness. …”
    Get full text
    Article
  2. 1462

    The Heart’s Secret Bridge: Ruptured Sinus of Valsalva Aneurysm Masquerading as a Gerbode Defect by Khalid Sawalha, Angel Lopez-Candales

    Published 2024-07-01
    “…Our case presents a 53-year-old male with type 2 diabetes and dyslipidemia presenting to the emergency department with symptoms of chest pressure, palpitations, dyspnea, and exercise intolerance. …”
    Get full text
    Article
  3. 1463

    Pregnancy Complicated by Maternal MODY 3 and Paternal MODY 2 Diabetes and Subsequent Rapidly Falling Insulin Requirement by Anastasia Mikuscheva, Adel Mekhail, Benjamin J. Wheeler

    Published 2018-01-01
    “…‘Maturity-Onset Diabetes of the Young’ (MODY) or monogenic diabetes accounts for approximately 1–2% of diabetes and is frequently misdiagnosed as type 1 or type 2 diabetes. Here we report a case of a 19-year-old pregnant woman with a MODY 3 diabetes expecting a child to a father with MODY 2 diabetes. …”
    Get full text
    Article
  4. 1464

    Hubungan Jumlah Komplikasi Kronik Dengan Derajat Gejala Depresi Pada Pasien Diabetes Melitus Tipe 2 Di Poliklinik Rsup Dr. M. Djamil Padang by Try Rahmi Lussii Karsuita, Eva Decroli, Delmi Sulastri

    Published 2016-09-01
    “…</em></p><strong><em>Keywords: </em></strong><em>:</em><em>type 2 diabetes mellitus, depression symptoms, chronic complications</em>…”
    Get full text
    Article
  5. 1465
  6. 1466
  7. 1467

    Decreased Levels of Insulin-Regulated Aminopeptidase (IRAP) in Gestational Diabetes Mellitus: A Prospective Cohort Study by Osman Köse, Koray Gök, Elif Köse, Sezen Irmak Gözükara, Abdullah Tüten, Mehmet Sühha Bostancı

    Published 2025-01-01
    “…Background: Insulin-regulated aminopeptidase (IRAP) is involved in insulin sensitivity and glucose metabolism and is important in the pathophysiology of type 2 diabetes. Serum IRAP levels are strongly associated with type 2 diabetes and insulin resistance. …”
    Get full text
    Article
  8. 1468

    The Long and Short of It: The Role of Telomeres in Fetal Origins of Adult Disease by Stephanie E. Hallows, Timothy R. H. Regnault, Dean H. Betts

    Published 2012-01-01
    “…Following IUGR, there is an increased risk for cardiovascular disease and Type 2 Diabetes. The etiology of these diseases is beginning to be elucidated, and premature aging or cellular senescence through increased oxidative stress and DNA damage to telomeric ends may be initiators of these disease processes. …”
    Get full text
    Article
  9. 1469

    The Mediterranean Lifestyle: The Power of Food by Charissa Lim, Alexa Hosey, Farah Tadros, Madison Woodard, Jeanette Andrade

    Published 2020-11-01
    “…This dietary pattern has been shown to improve heart health, maintain weight, and reduce the risk for chronic diseases such as cardiovascular disease and type 2 diabetes. This new 6-page publication discusses the Mediterranean dietary pattern and provides tips to incorporate this lifestyle into daily life, as well as sample recipes. …”
    Get full text
    Article
  10. 1470

    Acute Kidney Injury Associated with Linagliptin by Deepak K. Nandikanti, Elvira O. Gosmanova, Aidar R. Gosmanov

    Published 2016-01-01
    “…Linagliptin is a dipeptidyl peptidase-IV (DPP-IV) inhibitor that is approved for the treatment of type 2 diabetes mellitus. About 5% of linagliptin is eliminated by the kidneys and no dose adjustment is recommended in kidney impairment. …”
    Get full text
    Article
  11. 1471

    Acute Pancreatitis in Individuals with COVID-19: A Case Report and Critical Review of Literature by Arsia Jamali, Khashayar Nemovi, Betul N. Bayraktutar, Adam Farzaneh, Kevin Chan, Carlos Ramirez, Elika Shahkamrani, Anil Perumbeti

    Published 2022-01-01
    “…Herein, we report a case of 65-year-old woman with type 2 diabetes mellitus, hypertension, and end-stage renal disease undergoing hemodialysis who was initially diagnosed with COVID-19 on a screening test. …”
    Get full text
    Article
  12. 1472

    Diabetes and Coronary Heart Disease: A Risk Factor for the Global Epidemic by Maguy Chiha, Mario Njeim, Edgar G. Chedrawy

    Published 2012-01-01
    “…In this we will paper focus on type 2 diabetes mellitus as a risk factor for coronary heart disease, review the mechanisms of atherogenesis in diabetics, the impact of hypertension and the treatment goals in diabetics, the guidelines for screening, and review the epidemiologic consequences of diabetes and heart disease on a global scale. …”
    Get full text
    Article
  13. 1473

    Reversal of the Symptoms of Diabetic Neuropathy through Correction of Vitamin D Deficiency in a Type 1 Diabetic Patient by David S. H. Bell

    Published 2012-01-01
    “…Vitamin D deficiency has been associated with both type 1 and type 2 diabetes as well as both the microvascular and macrovascular complications of diabetes. …”
    Get full text
    Article
  14. 1474

    Hot pants: The emerging field of exercise mimetics, from hospital beds to the international space station by Kevin John

    Published 2024-11-01
    “…A relevant and current example of this is the enormous market demand for glucagon‐like peptide‐1 drugs for the management of obesity and type‐2 diabetes. The goal of this short review is to direct attention toward non‐pharmaceutical strategies and specifically focuses on the topical application of heat stress to passively improve health. …”
    Get full text
    Article
  15. 1475

    Linking gut microbiota to aging process: a new target for anti-aging by Maoyang Lu, Zhao Wang

    Published 2018-06-01
    “…Gut microbiota is linked to lots of diseases, including human metabolic diseases such as obesity, type 2 diabetes (T2D), irritable bowel syndrome, and cardiovascular disease (CVD). …”
    Get full text
    Article
  16. 1476

    The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease by T. S. Krolevets, M. A. Livzan, S. I. Mozgovoy

    Published 2020-12-01
    “…The role of the human microbiome in the development and progression of NAFLD is associated with its effects on the risk factors (obesity, insulin resistance, type 2 diabetes), permeability of the intestinal barrier and absorption of such substances as short-chain fatty acids, bile acids, choline and endogenous ethanol. …”
    Get full text
    Article
  17. 1477

    Proinflammatory Effects of C-Peptide in Different Tissues by Dusica Vasic, Daniel Walcher

    Published 2012-01-01
    “…C-peptide as a cleavage product of proinsulin is in the last few decades known as an active peptide with a number of different effects on microvascular and macrovascular complications in type 2 diabetic patients. Patients with insulin resistance and early type 2 diabetes show elevated levels of C-peptide in blood. …”
    Get full text
    Article
  18. 1478

    Multifactorial Induction of a “Scleroderma‐Like Pattern” Without Underlying Connective Tissue Disease: Diagnostic and Therapeutic Implications by Angelo Nigro

    Published 2025-01-01
    “…A 60‐year‐old man with a significant 20‐year history of smoking, averaging approximately 20 cigarettes per day, presented with type 2 diabetes mellitus, hypercholesterolemia, and hypertension. …”
    Get full text
    Article
  19. 1479

    Otyłość - ważny problem zdrowotny by Grażyna Nowicka

    Published 2005-12-01
    “…Managing of obesity and overweight is of paramount importance because of well established relations between excess body mass and different diseases such as coronary heart disease, type 2 diabetes, hypertension, and some types of cancer. …”
    Get full text
    Article
  20. 1480

    Safety and Mode of Action of Diabetes Medications in comparison with 5-Aminolevulinic Acid (5-ALA) by Peter R. Rehani, Hanaa Iftikhar, Motowo Nakajima, Tohru Tanaka, Zaid Jabbar, Riyadh N. Rehani

    Published 2019-01-01
    “…Thus, in this review, we evaluate the mechanisms of action and adverse effects of common medications used to treat type 2 diabetes mellitus as well as 5-ALA including its mechanism and possible use in diabetes management.…”
    Get full text
    Article